Title: |
Phase I Trial of Targeted Alpha-Particle Immunotherapy with Actinium-225 (225Ac)-Lintuzumab (Anti-CD33) and Low-Dose Cytarabine (LDAC) in Older Patients with Untreated Acute Myeloid Leukemia (AML) |
Source: |
Blood
[0006-4971]
Jurcic,
Joseph
yr:2015
|
|
|
|